Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FES-Rowing Versus Zoledronic Acid to Improve Bone Health in SCI: A Comparative Clinical Trial

NCT01426555 is registered in ClinicalTrials.gov with Antonio Lazzari as lead sponsor.

NCT NCT01426555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01426555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FES-Rowing Versus Zoledronic Acid to Improve Bone Health in SCI: A Comparative Clinical Trial
Lead sponsor
Antonio Lazzari
Phase
Phase 2/3
Overall status
Terminated
Start date
February 28, 2011
Completion date
February 28, 2015
Enrollment
70 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis